My Healthcare News & Research — June 21, 2026 · Lactulose — The Milk Sugar That Feeds Gut Bacteria and Traps Ammonia

Scientific infographic showing how lactulose passes undigested to the colon, is fermented by gut bacteria into acids that lower pH, feeds Bifidobacterium and Lactobacillus, traps ammonia as ammonium, and may reduce kidney-bound uremic toxins
The lactulose pathway in one picture: a non-digestible milk sugar that human enzymes cannot split, fermented by colon bacteria into acids that lower pH — trapping nitrogen as ammonium, feeding beneficial microbes, and routing waste into the stool instead of the bloodstream. Click to zoom.

Most people meet lactulose on a pharmacy shelf labeled simply “laxative,” and most never look past that label. But lactulose is one of the more scientifically interesting molecules in the medicine cabinet, because it does almost nothing to your body directly. It is not absorbed. It does not stimulate the bowel wall. Your digestive enzymes cannot even break it apart. What it actually does is feed the trillions of bacteria living in your colon — and it is their metabolism, not yours, that produces every one of lactulose’s effects: the softer stool, the gas, the drop in blood ammonia that makes it a frontline liver-failure medicine, and the still-emerging signal that it may lighten the waste load on failing kidneys.

This edition takes lactulose apart from the microbe’s point of view. The thread that ties it all together — and the part most worth understanding — is nitrogen: where ammonia comes from, why an acidic colon traps it, and how a sugar that bacteria eat can end up exporting nitrogen waste into the toilet instead of the bloodstream. That single mechanism is why the same cheap syrup shows up in cirrhosis wards and in kidney-disease research.

Table of Contents

  1. 1. What Lactulose Actually Is
  2. 2. Made From Milk Sugar, Not Petroleum
  3. 3. How It Works: Osmosis Plus Fermentation
  4. 4. Lactulose vs. PEG 3350 vs. Kiwifruit
  5. 5. A Prebiotic, Not Just a Laxative
  6. 6. The Ammonia Story — Why Liver Medicine Relies on It
  7. 7. The Gut–Kidney Axis — A Plausible, Emerging Benefit
  8. 8. The Unifying Idea: Lactulose Routes Nitrogen Out of the Body
  9. 9. Practical Notes: Dosing, Prescription Status, Cautions
  10. Key Research Papers
  11. PubMed Topic Searches
  12. Connections
  13. Featured Videos

1. What Lactulose Actually Is

Lactulose is a synthetic sugar — a disaccharide, meaning two simple sugars joined together. In its case the two halves are galactose and fructose, chemically written as 4-O-β-D-galactopyranosyl-D-fructose. It is a close cousin of lactose, the natural sugar in milk, which is galactose joined to glucose. The only difference is which sugar sits on one half of the molecule and the exact bond that links them — but that small difference is everything.

Humans produce an enzyme (lactase) that splits lactose so we can absorb it. We make no enzyme that can split the galactose–fructose bond in lactulose. So lactulose travels the length of the small intestine essentially untouched, arriving in the colon intact and still carrying all of its chemical energy. That single fact — indigestible by us, but edible by bacteria — is the source of every effect described in this article. Lactulose is best understood not as a drug that acts on you, but as food delivered specifically to your colon’s microbes.

2. Made From Milk Sugar, Not Petroleum

A question we hear often — usually from people trying to avoid petrochemical-derived products — is where lactulose comes from. The answer is reassuring on that count: commercial lactulose is manufactured from lactose, the natural sugar of milk, typically purified from whey, a byproduct of cheese-making. There is no petroleum feedstock in the chain.

The manufacturing logic is elegant. Lactose is galactose-plus-glucose; lactulose is galactose-plus-fructose. Glucose and fructose are isomers — the same atoms arranged differently — so converting one into the other does not require building anything new, only rearranging it. Industrially this is done by alkaline isomerization: lactose is treated under controlled alkaline conditions (often with a catalyst) that flip the glucose half of the molecule into a fructose half, turning lactose into lactulose. The syrup is then purified to remove unreacted lactose and side products. Newer routes use enzymes (such as cellobiose 2-epimerase) or even electrochemical methods to do the same isomerization more cleanly. The takeaway is simple: lactulose is manufactured rather than foraged — it is not abundant in any natural food — but its raw material is a milk sugar, not a barrel of oil.

3. How It Works: Osmosis Plus Fermentation

When lactulose reaches the colon, two things happen at once, and both come from the bacteria.

  1. Fermentation. Gut bacteria consume lactulose as fuel and ferment it into small organic acids — chiefly lactic acid and acetic acid, with smaller amounts of other short-chain fatty acids.
  2. Osmosis. Those acids, plus the un-fermented sugar itself, raise the osmotic pressure inside the colon. Water is pulled into the bowel to balance it. Stool becomes softer, bulkier, and easier to pass.

This is why lactulose is classified as an osmotic laxative — but note that the osmotic effect is partly a downstream product of fermentation, not a purely physical effect. The same fermentation explains the most common complaint: gas, bloating, abdominal rumbling, and mild cramping, especially in the first days of use. If your colon gurgles after a dose, that sound is literally your bacteria metabolizing the sugar — evidence the mechanism is working, even if it is uncomfortable.

One practical consequence of working through bacteria rather than by irritating the bowel: lactulose is not fast. It typically takes 24–48 hours, and sometimes up to 72 hours, to produce its full effect. It does not “force” the bowel the way a stimulant laxative does. People expecting a same-day result from a single dose are often disappointed; lactulose rewards patience and regularity.

4. Lactulose vs. PEG 3350 vs. Kiwifruit

Because readers frequently compare laxative options — particularly those wary of synthetic polymers — here is how lactulose lines up against polyethylene glycol 3350 (PEG, sold as MiraLAX and others) and against the gentle food approach of kiwifruit.

Feature Lactulose PEG 3350
Origin Made from milk sugar (lactose) Petrochemical-derived polymer
Fermented by gut bacteria? Yes — this is the whole point No — chemically inert
Gas and bloating Common Less common
Mechanism Osmotic plus bacterial fermentation Osmotic only
Prebiotic / microbiome effect Yes (feeds beneficial bacteria) Minimal to none
Taste / form Sweet syrup Nearly tasteless powder

The two are genuinely different tools. PEG is an inert polymer: it holds water in the stool and passes through without your bacteria touching it, which is exactly why it causes less gas. Lactulose does the opposite — it is meant to be eaten by your microbes, and the gas is the cost of the microbiome benefit. Neither origin makes one “clean” and the other “toxic”; the honest distinction is mechanistic, not moral. If your priority is avoiding a petroleum-derived compound, lactulose is the milk-sugar option. If your priority is the least possible gas, PEG has the edge.

For mild, occasional constipation, food can do a surprising amount of the work. Randomized trials have found that two green kiwifruit per day improve bowel frequency and stool comfort about as well as some low-dose laxative approaches, working through fiber, water-holding capacity, and gentle continuous fermentation rather than a single osmotic push. A reasonable way to think about it: kiwifruit (or prunes) supports day-to-day regularity; lactulose is the stronger, more predictable intervention when you actually need to move things along.

5. A Prebiotic, Not Just a Laxative

Here is the part the “laxative” label hides. Because lactulose is fermented by bacteria, it meets the textbook definition of a prebiotic: a non-digestible substrate that selectively nourishes beneficial members of the gut community. And the bacteria it favors are the ones most people are trying to cultivate with expensive probiotic products:

As these microbes ferment lactulose, they pour out lactic acid, acetic acid, and short-chain fatty acids, which lower the pH of the colon — making it more acidic. That acidity is itself selective: it favors acid-tolerant beneficial species and suppresses several potentially harmful, pH-sensitive organisms. The result is a measurable shift in the whole ecosystem, not just a bowel movement.

The dose is what separates the two faces of lactulose. A 2021 review in Frontiers in Nutrition by Karakan and colleagues pooled nine clinical trials totaling 537 participants and found that low doses — roughly 5–10 g/day — produce the prebiotic effect (higher Bifidobacterium and Lactobacillus counts, more short-chain fatty acids, lower fecal pH, fewer harmful bacteria) without the strong laxative effect that appears only at the much higher 30–60 g/day doses used for constipation. In a randomized double-blind trial, Bouhnik and colleagues showed that just 5 g twice daily for six weeks significantly raised fecal bifidobacterial counts in healthy adults. Controlled-laboratory gut models confirm the effect is dose-dependent and reproducible.

So someone taking a single 15 mL sachet (about 10 g of lactulose) once a week is, in microbiome terms, giving their Bifidobacterium and Lactobacillus populations a periodic meal — a real, if intermittent, prebiotic dose. The feeling of “working better afterward” that regular users describe is partly the bowel emptying and partly this shift in which bacteria are being fed.

6. The Ammonia Story — Why Liver Medicine Relies on It

This is where the evidence for lactulose is strongest, and where the nitrogen story begins. In advanced liver disease and cirrhosis, the liver can no longer clear ammonia — a nitrogen-rich waste product made largely by gut bacteria as they break down protein. Ammonia builds up in the blood, crosses into the brain, and causes hepatic encephalopathy: confusion, disorientation, tremor, and in severe cases coma. Lactulose is a frontline treatment for it, and the reason is pure chemistry happening in the colon:

  1. The acid trap. Ammonia (NH3) and ammonium (NH4+) exist in a balance that depends on pH. NH3 is a small, uncharged molecule that slips easily across the gut wall into the blood. NH4+ is charged and cannot be absorbed. By fermenting lactulose into acids and dropping colonic pH, lactulose pushes the balance toward NH4+, locking ammonia inside the gut where it cannot reach the brain.
  2. Bacterial uptake. The blooming, well-fed bacteria need nitrogen to build their own bodies, so they pull ammonia out of the gut contents and incorporate it into their biomass. That nitrogen is now inside bacterial cells.
  3. Export in stool. The laxative effect then carries those nitrogen-loaded bacteria, and the trapped ammonium, out of the body in the feces — before the nitrogen can be reabsorbed.

The clinical evidence is unusually solid for a humble syrup. A 2016 Cochrane systematic review by Gluud, Vilstrup, and Morgan pooled 38 randomized controlled trials and found that non-absorbable disaccharides such as lactulose reduced the risk of hepatic encephalopathy (risk ratio 0.58, 95% CI 0.50–0.69) and — remarkably — reduced mortality (risk ratio 0.59, 95% CI 0.40–0.87) compared with placebo or no treatment. The numbers needed to treat were about 6 to improve encephalopathy and 19 to prevent one death. The 2022 EASL clinical practice guidelines accordingly list lactulose as first-line therapy. Whatever else lactulose is, in the liver context it is a genuine, life-saving drug — and it works entirely by managing gut bacteria and nitrogen.

7. The Gut–Kidney Axis — A Plausible, Emerging Benefit

Now the question that prompted this article: if lactulose can lighten the nitrogen burden on the brain in liver failure, could the same trick lighten the waste burden on failing kidneys? The honest answer is: the mechanism is biologically plausible and the early data are encouraging, but this is not established therapy. Here is exactly what is known, graded honestly.

Where the toxins come from

The kidneys clear many waste compounds, and a surprising share of them originate in the gut. Bacteria metabolize dietary amino acids into precursors — indole (from tryptophan) and p-cresol (from tyrosine and phenylalanine) — that are absorbed and converted by the liver into indoxyl sulfate and p-cresyl sulfate. These are called uremic toxins because they accumulate to harmful levels when kidney function declines, and they are linked to faster kidney decline and cardiovascular damage. Crucially, the bacteria that produce indole — certain Bacteroides and Clostridium species — are different from the Bifidobacterium and Lactobacillus that lactulose feeds.

What the studies show

Animal evidence. In a 2019 study in Clinical and Experimental Nephrology, Sueyoshi and colleagues gave lactulose to rats with adenine-induced chronic kidney disease. The treated animals showed lower serum indoxyl sulfate and p-cresyl sulfate, improved serum creatinine and blood urea nitrogen, and significantly less kidney scarring (tubulointerstitial fibrosis). The microbiome explained it: lactulose increased Bifidobacterium and reduced the indole-producing Bacteroides and Clostridium cluster XI — fewer toxin-makers, more beneficial fermenters.

Human evidence. A small randomized trial by Tayebi-Khosroshahi and colleagues (2016) gave 32 patients with stage 3–4 chronic kidney disease either lactulose syrup (30 mL three times daily) or placebo for eight weeks. In the lactulose group, fecal Bifidobacteria and Lactobacilli counts rose significantly, and serum creatinine fell modestly (from 3.90 to 3.60 mg/dL, p = 0.003) while it rose in the placebo group. That is a real, measured signal in actual patients.

The honest limits

Now the part a good skeptic should hold onto. This evidence is one rodent study and one 32-person trial, plus supporting microbiome reviews — not the dozens of large randomized trials that back the liver use. The human creatinine change was modest. Lactulose is not an approved kidney treatment, has not been shown to prevent kidney failure, and nephrologists do not prescribe it for kidney function alone. The right way to read this is as a legitimate, testable hypothesis with promising early support, not a settled benefit. The interesting scientific questions — does it raise Bifidobacterium, increase short-chain fatty acids, lower indoxyl sulfate, and slow decline in large trials? — are measurable, and independent of anyone’s authority. They simply have not all been answered yet at the scale that would change practice.

8. The Unifying Idea: Lactulose Routes Nitrogen Out of the Body

Step back, and the liver use and the kidney hypothesis turn out to be the same mechanism viewed from two ends. Lactulose does not act on the liver or the kidney directly. It acts on bacteria, and through them, on nitrogen routing:

  1. Lactulose reaches the colon undigested and feeds bacteria.
  2. The bacteria multiply, ferment it into acids, and make the colon more acidic.
  3. Growing bacteria pull nitrogen into their own biomass; the acidic environment simultaneously traps ammonia as ammonium so it cannot be absorbed.
  4. The colon becomes a larger “sink” for nitrogen, and the laxative effect exports that nitrogen in the stool.
  5. Less nitrogen-containing waste enters the bloodstream in the first place — whether that waste is the ammonia that poisons the brain in liver failure, or the gut-derived precursors of the uremic toxins the kidneys would otherwise have to clear.

That is the whole idea in one line: lactulose → gut bacteria → nitrogen handling and microbial metabolites → less waste burden entering the circulation. The brain benefit is proven; the kidney benefit is the same lever, applied one organ over, and still being measured.

9. Practical Notes: Dosing, Prescription Status, Cautions

Prescription status. In the United States, lactulose oral solution is generally prescription-only (“Rx only”) per FDA-approved labeling. This is largely a quirk of regulatory history — it was approved that way decades ago and no manufacturer pursued the separate process to switch it to over-the-counter — rather than a sign of unusual danger. Lactulose is poorly absorbed and acts locally; in much of Asia and Europe it is sold over the counter or directly by a pharmacist (for example, Duphalac, commonly 10 g per 15 mL sachet).

Typical dosing. For constipation, adult dosing often starts at 15–30 mL daily (about 10–20 g) and is adjusted to response; for hepatic encephalopathy, doses are higher and titrated to produce two to three soft stools per day. For prebiotic effect, the research above points to a much lower ~5–10 g/day. Remember the 24–72 hour onset — it is not a same-day fix.

A gentle correction worth making. Regular users often say lactulose “cleans out the intestine.” Physiologically that is not quite what happens — lactulose does not scrub the gut wall or remove “toxins” in the detox sense. It draws in water, softens and bulks the stool, and shifts which bacteria and metabolites dominate, which helps the bowel empty more completely and comfortably. That can feel like being cleaned out, and it is a real and useful effect — it is just worth naming accurately.

Cautions. Lactulose contains galactose and small amounts of other sugars, so it is contraindicated in galactosemia (an inherited inability to handle galactose). People with diabetes should be aware it contains some free sugars, though the glycemic impact is usually small. The fermentation-driven gas, bloating, and cramping are the most common nuisances and often ease with time or a lower starting dose. Overuse can cause diarrhea and, with significant fluid loss, electrolyte disturbance — a particular reason for people with advanced kidney disease to use it only under medical guidance. As always on this site: this article is education, not a prescription — decisions about using lactulose for any medical condition belong with you and your clinician.

Key Research Papers

Prebiotic & Gut-Bacteria Effects

  1. Karakan T, Tuohy KM, Janssen-van Solingen G. Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption. Frontiers in Nutrition. 2021;8:672925. doi:10.3389/fnut.2021.672925 (PMID 34386514)
  2. Bouhnik Y, Attar A, Joly FA, et al. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. European Journal of Clinical Nutrition. 2004;58(3):462–466. doi:10.1038/sj.ejcn.1601829
  3. Bothe MK, Maathuis AJH, Bellmann S, et al. Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine. Nutrients. 2017;9(7):767. doi:10.3390/nu9070767 (PMID 28718839)

Ammonia & Hepatic Encephalopathy (Strongest Evidence)

  1. Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews. 2016;(5):CD003044. doi:10.1002/14651858.CD003044.pub4 (PMID 27089005)
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. Journal of Hepatology. 2022;77(3):807–824. journal-of-hepatology.eu

Gut–Kidney Axis & Uremic Toxins (Emerging Evidence)

  1. Sueyoshi M, Fukunaga M, Mei M, et al. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clinical and Experimental Nephrology. 2019;23(7):908–919. doi:10.1007/s10157-019-01727-4 (PMID 30895529)
  2. Tayebi-Khosroshahi H, Habibzadeh A, Niknafs B, et al. The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial. Journal of Renal Injury Prevention. 2016;5(3):162–167. doi:10.15171/jrip.2016.34

Chemistry & Manufacture

  1. Karim A, Aïder M. Sustainable Electroisomerization of Lactose into Lactulose and Comparison with the Chemical Isomerization at Equivalent Solution Alkalinity. ACS Omega. 2020;5(5):2318–2333. doi:10.1021/acsomega.9b03705

PubMed Topic Searches

  1. PubMed: lactulose prebiotic Bifidobacterium
  2. PubMed: lactulose hepatic encephalopathy ammonia
  3. PubMed: lactulose chronic kidney disease uremic toxins
  4. PubMed: indoxyl sulfate p-cresyl sulfate gut microbiota
  5. PubMed: gut-kidney axis chronic kidney disease
  6. PubMed: lactulose short-chain fatty acids colonic pH

Connections

Back to Table of Contents